NCT02171910View on ClinicalTrials.gov

Doxapram as an Additive to Propofol Sedation in Sedation for ERCP

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
SedationHypoxia
Interventions
DRUG

Doxapram

DRUG

Placebo

An injection and infusion of normal saline (NaCl 0.9%) as a placebo comparator to doxapram

Trial Locations (1)

00029 HUS

Helsinki University Central Hospital, Helsinki

All Listed Sponsors
lead

Helsinki University Central Hospital

OTHER

NCT02171910 - Doxapram as an Additive to Propofol Sedation in Sedation for ERCP | Biotech Hunter | Biotech Hunter